Adam H. Hennessey

Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations.

Summit Partners invests in companies located across the globe. The firm targets companies operating in the fields of technology, healthcare & life sciences and growth products & services sectors. It provides financing for buyout, recapitalizations and growth transactions with an investment size of USD 10 - 500 million. The fund acquires majority or minority stakes.

Provides auditing, assurance, consulting and tax & business consulting services

Functions as a College/University

Functions as a College/University